Antimicrobiens

Erythromycylamine is a semisynthetic antibiotic, which is derived from the parent compound erythromycin. This compound is sourced from the fermentation product of the bacterium *Saccharopolyspora erythraea*. Erythromycylamine acts by inhibiting bacterial protein synthesis, specifically targeting the 50S ribosomal subunit, which ultimately leads to the disruption of bacterial cell growth and replication.

Artefenomel is an antimalarial agent, which is a synthetic derivative originally based on artemisinin, primarily sourced from the Artemisia annua plant. It exhibits its mode of action by targeting and disrupting the Plasmodium parasite's life cycle within the human host. Specifically, artefenomel interferes with the parasite's ability to degrade hemoglobin, leading to the accumulation of toxic levels of heme, ultimately causing the parasite's death.

Hexazinone metabolite D is a derivative compound that results from the biotransformation of Hexazinone, which is a systemic herbicide. This metabolite originates from the breakdown processes mediated by biological or environmental factors in ecosystems where Hexazinone is applied. Its mode of action involves the inhibition of photosynthesis by targeting photosystem II, ultimately reducing the transfer of electrons, which leads to the disruption of energy production in susceptible plant species.

Clomeprop (free acid) is a selective herbicide, which is synthesized chemically to target grass species. Its mode of action involves the inhibition of the enzyme acetyl-CoA carboxylase, crucial for fatty acid synthesis. This interferes with lipid production, which is vital for plant growth and development.

Bisphenol A d14 is an isotopically labeled compound, which is a variant of Bisphenol A (BPA) where hydrogen atoms are partially replaced with deuterium isotopes. This compound is produced through chemical synthesis, ensuring that 14 of the hydrogen atoms in the BPA molecule are replaced by deuterium to create a stable form with a slightly higher atomic mass, facilitating advanced analytical studies.

Fenamiphos-sulfoxide d3 (S-methyl d3) is a deuterated, labeled pesticide intermediate, which is often utilized in advanced laboratory settings for precise analytical studies. This compound is synthesized as a stable isotope-labeled analog, enabling researchers to conduct sophisticated mass spectrometric analyses. Its mode of action involves serving as a reference or tracer in studies concerning the metabolism and degradation of fenamiphos, a well-known organophosphate pesticide.

Fosmanogepix is a novel antifungal prodrug, which is derived from manogepix. This product is a synthetic compound, designed to target invasive fungal infections through its unique mechanism of action. The prodrug itself is inactive until metabolized in the body, where it converts into its active form, manogepix. This activation occurs through enzymatic hydrolysis, enabling it to exert its antifungal effects.

6-[(1,1-Dimethylethyl)amino]-1,3,5-triazine-2,4(1H,3H)-dione, commonly known as Terbuthylazine, is a selective systemic herbicide, which is synthesized chemically and primarily sourced from the triazine group of compounds. It operates by inhibiting photosynthesis, specifically interfering with the electron transport in photosystem II. This disruption in the photosynthetic pathway effectively halts the growth of susceptible weed species.

Propiconazole is a triazole fungicide with action on fungal cell membranes by inhibiting ergosterol biosynthesis and is used for controlling fungal diseases in crops and turf.

Fluconazole hydrate is an antifungal medication, which is a synthetic triazole antifungal agent derived from the compound fluconazole. It functions as a powerful inhibitor of the enzyme lanosterol 14α-demethylase, a critical component in the biosynthesis of ergosterol. Ergosterol is an essential component of fungal cell membranes, and its inhibition disrupts membrane synthesis, leading to impaired fungal cell growth and replication.

Please enquire for more information about Rilopirox including the price, delivery time and more detailed product information at the technical inquiry form on this page

Phenamacril is a synthetic fungicide, which is derived from chemical synthesis processes with a unique mode of action that targets fungal signaling pathways. It operates by inhibiting the myosin-5 ATPase activities within filamentous fungi, disrupting key cellular functions and effectively halting fungal growth.

Cyclosporin L is an immunosuppressive agent, which is a cyclic polypeptide derived from the soil fungus Tolypocladium inflatum. It primarily functions by inhibiting the activity of calcineurin, a key phosphatase involved in the activation of T-cells. This inhibition prevents the transcription of interleukin-2 and other cytokines critical for T-cell proliferation.

Cefdinir monohydrate is a third-generation cephalosporin antibiotic, which is synthetically derived from cephalosporin C, a compound originally isolated from the fungus Acremonium. This antibiotic works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), which results in the interruption of peptidoglycan cross-linking. Consequently, this action leads to cell lysis and death of the bacterium.

Dimethenamid-oxalamid is a pre-emergent herbicide, which is a synthetic compound developed for agricultural use. It is derived from research focused on improving crop protection through chemical innovation. The mode of action involves inhibiting the synthesis of very long-chain fatty acids (VLCFAs) in weeds, disrupting their cell division and growth processes, ultimately leading to the prevention of weed emergence.

Rifamycin PR-14 is a semi-synthetic antibiotic, which is derived from the naturally occurring antibiotic rifamycin. Originating from a fermentation process involving the bacterium Amycolatopsis mediterranei, rifamycin is modified to create the PR-14 variant to enhance its antibacterial properties and pharmacokinetic profile. This compound functions by inhibiting bacterial DNA-dependent RNA polymerase, effectively halting RNA synthesis and subsequent protein production, leading to bacterial cell death.

MGB-BP-3 is a synthetic antimicrobial agent, which is derived from natural DNA-binding minor groove binder (MGB) compounds. Its structure is based on distamycin, known for targeting the minor groove of DNA. MGB-BP-3 operates by binding to specific sequences within the DNA minor groove, thereby interfering with the replication and transcription processes of bacterial cells. This binding disrupts the DNA function and inhibits the growth and proliferation of bacterial pathogens.

Amrubicin hydrochloride is an anthracycline chemotherapeutic agent, which is a synthetic anthracycline derivative derived from reductive amination. It functions primarily by intercalating into DNA and inhibiting topoisomerase II, an enzyme crucial to DNA replication. This mode of action disrupts DNA synthesis, leading to apoptosis in rapidly proliferating cancer cells.

6-Chloro didesacetyl famciclovir is a synthetic antiviral compound, which is derived from famciclovir, with specific modifications to enhance its biochemical properties. It is a chlorinated analog resulting from structural alterations to famciclovir, a prodrug of the antiviral agent penciclovir.

Cefepime-d3 sulfate is an isotopically labeled antibiotic, which is derived from the fourth-generation cephalosporin, cefepime. The source of this compound is synthetic, utilizing deuterium to label the parent cefepime molecule, allowing for detailed metabolic and pharmacokinetic studies. With deuterium's stable, non-radioactive nature, it serves as a powerful tool in mass spectrometry-based analyses.

N-Demethylclindamycin is a metabolite of clindamycin, which is a semi-synthetic antibiotic derived from the naturally occurring compound lincomycin. This product is synthesized by enzymatic or chemical processes that remove the N-methyl group from clindamycin's molecular structure, making it an important derivative in the study of antibiotic activity and metabolic pathways.